 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 78 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Neve R. on LIVE DISCUSSION: Presenilin Loss of Function—Plan B for AD?, Thank you to Jie Shen and Raymond Kelleher for kicking off this discussion with their very... 13 Mar 2007.
|
|
|
 |
|
|
Neve R. on PAPER: Sundararajan S. et al., 2006, Recommendation Only. 18 Jun 2006.
|
|
|
|
|
|
Neve R. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, Three papers published within the last 2 weeks highlight the potential importance of presenilin... 17 May 2006.
|
|
|
|
|
|
Neve R. on PAPER: Theuns J. et al., 2006, Recommendation Only. 16 May 2006.
|
|
|
|
|
|
Neve R. on PAPER: Shaked GM. et al., 2006, Recommendation Only. 3 May 2006.
|
|
|
|
|
|
Neve R. on PAPER: Andersen OM. et al., 2006, Recommendation Only. 6 Mar 2006.
|
|
|
|
|
|
Neve R. on PAPER: Wagner B. et al., 2006, Recommendation Only. 27 Feb 2006.
|
|
|
|
|
|
Neve R. on PAPER: Khurana V. et al., 2006, Recommendation Only. 13 Feb 2006.
|
|
|
|
|
|
Neve R. on PAPER: Yang Y. et al., 2006, Recommendation Only. 31 Jan 2006.
|
|
|
|
|
|
Neve R. on PAPER: Crameri A. et al., 2006, Recommendation Only. 20 Jan 2006.
|
|
|
|
|
|
Neve R. on PAPER: Guénette S. et al., 2006, Recommendation Only. 20 Jan 2006.
|
|
|
|
|
|
Neve R. on PAPER: Kojro E. et al., 2006, Recommendation Only. 20 Jan 2006.
|
|
|
|
|
|
Neve R. on NEWS: APP Double Dose Causes Early-Onset AD, Obviously, the excitement of the paper derives from the fact that simple duplication of the APP... 22 Dec 2005.
|
|
|
|
|
|
Neve R. on PAPER: Yang Z. et al., 2006, Recommendation Only. 16 Dec 2005.
|
|
|
|
|
|
Neve R. on PAPER: Muresan Z. et al., 2005, Recommendation Only. 1 Dec 2005.
|
|
|
|
|
|
Neve R. on PAPER: Santos MJ. et al., 2005, Recommendation Only. 19 Oct 2005.
|
|
|
|
|
|
Neve R. on PAPER: Nagy Z. et al., 2005 Jul-Sep, Nagy proposes the very intriguing hypothesis that it is not cell cycle activation per se that... 18 Oct 2005.
|
|
|
|
|
|
Neve R. on PAPER: Kretzschmar D. et al., 2005, This is an excellent, well-written, thorough review that shows us that invertebrate models have... 2 Oct 2005.
|
|
|
|
|
|
Neve R. on PAPER: Brasnjevic I. et al., 2006, A very thoughtful commentary that provides good insights into how transgenic animal models for... 12 Sep 2005.
|
|
|
|
|
|
Neve R. on PAPER: Shah S. et al., 2005, Recommendation Only. 29 Aug 2005.
|
|
|
|
|
|
Neve R. on PAPER: Teo JL. et al., 2005, Recommendation Only. 29 Aug 2005.
|
|
|
|
|
|
Neve R. on PAPER: Spires TL. et al., 2005, Recommendation Only. 14 Aug 2005.
|
|
|
|
|
|
Neve R. on PAPER: Rockenstein E. et al., 2005, A number of human (h) BACE1 (β-site APP cleaving enzyme) transgenic mice have been generated and... 4 Aug 2005.
|
|
|
|
|
|
Neve R. on PAPER: Kelly BL. et al., 2005, Recommendation Only. 18 Jul 2005.
|
|
|
|
|
|
Neve R. on PAPER: Wiley JC. et al., 2005, This very interesting article presents data to support the idea that both class II FAD APP... 14 Jul 2005.
|
|
|
|
|
|
Neve R. on PAPER: Olry A. et al., 2005, This is a very clever approach for identifying cell lines that are defective in gamma-secretase... 27 Jun 2005.
|
|
|
|
|
|
Neve R. on PAPER: Small JA. et al., 2005, This is a fascinating study, and is potentially very useful for people who are taking care of... 18 Jun 2005.
|
|
|
|
|
|
Neve R. on PAPER: Webber KM. et al., 2005, This is an intriguing hypothesis, that cell cycle entry coincident with oxidative stress could... 18 Jun 2005.
|
|
|
|
|
|
Neve R. on PAPER: Andorfer C. et al., 2005, Recommendation Only. 18 Jun 2005.
|
|
|
|
|
|
Neve R. on PAPER: Park SY. et al., 2005, Recommendation Only. 18 Jun 2005.
|
|
|
|
|
|
|
1 to 30 of 78 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
